Home » Headlines » Currently Reading:

Morning Headlines 4/5/16

April 4, 2016 Headlines No Comments

New York’s Epic EHR ‘go-lives’ please officials, staff

Two NYC Health & Hospitals facilities are live with Epic after an April 1 go-live that a spokesman for the health system went well, explaining, “There were minor issues, but they were dealt with right away.”

Theranos Devices Often Failed Accuracy Requirements

A newly released CMS inspection report confirms that Theranos’ proprietary blood testing analyzer, Edison, failed internal quality control tests 29 percent of the time, while its California lab was also cited for doing tests with unqualified personnel and storing samples at the wrong temperatures.

Proteus Digital Health Presents Interim Results at ACC From a Randomized Controlled Clinical Study of Proteus Discover

Proteus Digital Health announces interim results from an RCT study of its smartpill technology, finding that its smartpill technology improves blood pressure control in hypertension patients significantly. 85 percent of patients using the smartpill achieved their target blood pressure within four weeks, while only 33 percent of participants in a control group receiving traditional care were able to do the same.

AMA taking bigger role in key IT initiatives

Michael Hodgkins, MD, CMIO of the American Medical Association, discusses interoperability and his role on the board of the Sequoia Project, formerly Healtheway.

View/Print Text Only View/Print Text Only


HIStalk Featured Sponsors

     







Subscribe to Updates

Search


Loading

Text Ads


Report News and Rumors

No title

Anonymous online form
E-mail
Rumor line: 801.HIT.NEWS

Tweets

Archives

Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reader Comments

  • Justa Trench Rat: Nice to see Cerner continuing with their new campus. I am sure our implementation of their highly questionable revenue ...
  • FRANK POGGIO: Shows to go ya...answering black and white Jeopardy questions is a far cry from the massive grey area of medicine/pharma...
  • Number Cruncher: You are right AC. The cost is seriously underestimated here. Just looking at the numbers - $1 B for 5 years = $200 M ...
  • Abraham Van Helsing: Re Theranos. Will be interesting to follow the saga. As I and others had noted going back 2+ years, something was obvi...
  • Prof. Moriarty: Re: Watson pull out. I've not been directly involved with this product, but from its beginning I have always seen Watso...
  • mih: Of course they can, and for much much cheaper. But why would they do it? Existing arrangement works for everyone in the ...
  • Andrew M. Harrison: Thanks for (actually) reading our paper. I enjoyed the story of your friend, as well as the translation of numbers to em...
  • Mike: I would love to see this type of discussion around Blockchain. It is being hyped heavily currently. Yet, I wonder how we...
  • Brian Too: Just slightly off-topic, but I recently heard an interesting downtime rule-of-thumb: Every hour of downtime requires 2 ...
  • James E Thompson: AI in particular isn't disruptive until it can offer an effective alternative against which a go/no-go decision makes se...

RSS Industry Events

  • An error has occurred, which probably means the feed is down. Try again later.

Sponsor Quick Links